Latest Breaking News On - Innocare pharma - Page 17 : comparemela.com

InnoCare Pharma: Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022

InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib for the treatment of Systemic

United statesHong kongChunhua luInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopeniaNeuromyelitis optica spectrum disorder

Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022

Latest Data of InnoCare s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongChunhua luInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationWall streetCare pharmaSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopenia

Stock Market | Daily Herald

Stock Market | Daily Herald
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongInnocare pharmaZhanguo liEuropean congressChina national medical products administrationNational reimbursement drugDrug administrationSystemic lupus erythematosusOral presentationBreakthrough therapy designationMultiple sclerosisPrimary immune thrombocytopeniaNeuromyelitis optica spectrum disorder

News - Licensing, China, Research

News - Licensing, China, Research
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHong kongUnited kingdomSouthwest finlandSouth koreaInnovent biologicsZenas biopharmaSutro biopharmaVerona pharmaInnocare pharmaLivzon mabpharmPregene biopharmaGenostics companyAssembly biosciencesZai lab

InnoCare Announces Approval to Conduct a Phase II Clinical Trial of Tafasitamab in Combination with Lenalidomide in China

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesHong kongJasmine cuiMorphosys incyteChunhua luInnocare pharmaTafasitamab monjuviChina national medical products administrationXencor incEuropean medicines agencyBoao lecheng international medical tourism pilot zoneDrug administrationHematology branch of chinese medical associationCare pharmaNational medical products administrationAntibody dependent cell mediated cytotoxicity